Pricing & Market Access
Our broad therapeutic expertise and institutional knowledge of key access decision makers and influencers help us develop unparalleled insights to inform our clients’ commercial strategy.
250+ Payer stakeholder interviews conducted last year
100+ Accessible payer organizations across the U.S. and E.U.
40% Consulting engagements with payer analysis
Project Types
Data-Driven Pricing & Market Access Solutions
Pricing Strategy
- Pricing & Contracting Strategy
- GTN Forecasting & Management, including Account- and Channel-specific Forecasts
- Revenue Preservation Strategies(e.g., authorized generics, NDC switches)
- Lifecycle Management Strategies(e.g., conversion, biosimilar defense)
- Patient Support, including Benchmarking, Design, & Modeling
Market Access Strategy
- Landscape Research & Scenario Planning
- Stakeholder Mapping & Funding Flow Analysis
- Launch Strategy
- Channel-Specific Access Strategies
- Key Account Management, Profiling, and Segmentation
- Patient Journey & Segmentation
- Model Policy
- Pre-Approval Information Exchange (PIE)
Value Strategy
- Evidence Generation Benchmarking & Strategy Development
- New Product Planning Strategy
- Value Proposition Development & Testing
- TPP Development & Testing
- Payer / Provider Engagement & Value Communication Strategy
- Practice Economics Analysis
- Budget Impact & Claims Analysis
Approach to Commercialization Assessments and Building Market Awareness
Pricing & Contracting Strategy
Objective
Develop ex-US pricing strategy for durable treatment based on need for value-based contracts
Approach
Identify payer value proposition by segment based on HEOR value
Define range of reimbursement scenarios
Develop and assess range of potential value-based contracts
Understand payer preferences regarding the need for and interest in value-based contracts
Commercial Assessment & Planning
Objective
Evaluate the value and preferences that payers have for different features of biosimilar products
Approach
Hypothesize potential payer “archetypes” that align with varying payer value propositions
Conduct virtual ad-boards and tele-depth interviews to pressure-test value propositions for payers
Explore payer willingness to partner with manufacturers to implement cost savings
Outline the payer “archetypes” that align with biosimilars